Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Assets    
Cash and cash equivalents $ 3,926 $ 2,361
Restricted cash 63 173
Accounts receivable, net 4,631 5,824
Inventories, net 4,869 6,580
Prepaid expenses and other current assets 4,074 2,641
Total Current Assets 17,563 17,579
Property and equipment, net 252 417
Right-of-use asset, operating lease 345 951
Intangible assets, net 13,115 14,641
Goodwill 18,614 18,614
Other assets 1,364 1,330
Total Assets 51,253 53,532
Current Liabilities    
Short term loan, net 7,826 16,061
Line of credit, net 0 4,819
PPP loans 190 0
Other liabilities 47 500
Accounts payable 3,137 4,049
Accrued liabilities 3,003 4,721
Deferred revenue 350 311
Operating lease liability, current portion 173 345
Warrant liability 39,850 0
Warrant derivative liability 0 2,220
Total Current Liabilities 54,576 33,026
Noncurrent Liabilities    
Notes payable, net 18,910 16,370
Line of credit, net 5,023 0
PPP loans 662 0
Operating lease liability 184 641
Total Noncurrent Liabilities 24,779 17,011
Total Liabilities 79,355 50,037
Redeemable Series E Convertible Preferred Stock    
Redeemable Series E preferred stock, $0.001 par value, 2,900,000 shares authorized, 0 & 1,387,378 shares issued and outstanding at December 31, 2020 and 2019, respectively 0 10,566
Stockholders’ Deficit    
Common stock, $0.001 par value, 200,000,000 and 88,000,000 shares authorized, 51,908,398 & 47,977,390 shares issued and outstanding at December 31, 2020 and 2019, respectively 52 48
Redeemable Series F Preferred Stock, $0.001 par value, 30,000 & 0 shares authorized, 21,754 & 0 shares issued and outstanding at December 31, 2020 and 2019, respectively 0 0
Additional paid-in capital 232,487 194,150
Accumulated deficit (260,641) (201,269)
Total Stockholders’ Deficit (28,102) (7,071)
Total Liabilities, Redeemable Preferred Stock and Stockholders’ Deficit $ 51,253 $ 53,532